| Jyotheen S Karam, MD | |
|
1617 Williams Dr, Ste. 200, Murfreesboro, TN 37129-3183 | |
| (615) 890-5484 | |
| (615) 890-7924 |
| Full Name | Jyotheen S Karam |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 28 Years |
| Location | 1617 Williams Dr, Murfreesboro, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619969482 | NPI | - | NPPES |
| 3331617 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 40035 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc Dialysis Assoc. Of Smyrna | Smyrna, TN | Dialysis facility |
| Dialysis Assoc. Of Murfreesboro-ht | Murfreesboro, TN | Dialysis facility |
| Saint Thomas Rutherford Hospital | Murfreesboro, TN | Hospital |
| Tristar Stonecrest Medical Center | Smyrna, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates, Pc | 0840282000 | 55 |
News Archive
Characterized by a buildup of amyloid plaques in the brain, Alzheimer's is an irreversible disease that leads to memory loss and a decrease in cognitive function.
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA.
Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.
Cases of esophageal cancer (adenocarcinoma) in the U.S. have risen in recent decades from 300,000 cases in 1973 to 2.1 million in 2001 at age-adjusted rates.
› Verified 3 days ago
| Entity Name | Nephrology Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700878360 PECOS PAC ID: 0840282000 Enrollment ID: O20040330001670 |
News Archive
Characterized by a buildup of amyloid plaques in the brain, Alzheimer's is an irreversible disease that leads to memory loss and a decrease in cognitive function.
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA.
Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.
Cases of esophageal cancer (adenocarcinoma) in the U.S. have risen in recent decades from 300,000 cases in 1973 to 2.1 million in 2001 at age-adjusted rates.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jyotheen S Karam, MD 1617 Williams Dr, Ste. 200, Murfreesboro, TN 37129-3183 Ph: (615) 890-5484 | Jyotheen S Karam, MD 1617 Williams Dr, Ste. 200, Murfreesboro, TN 37129-3183 Ph: (615) 890-5484 |
News Archive
Characterized by a buildup of amyloid plaques in the brain, Alzheimer's is an irreversible disease that leads to memory loss and a decrease in cognitive function.
Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA.
Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.
Cases of esophageal cancer (adenocarcinoma) in the U.S. have risen in recent decades from 300,000 cases in 1973 to 2.1 million in 2001 at age-adjusted rates.
› Verified 3 days ago
Joyline D James, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 3400 Lebanon Rd, Murfreesboro, TN 37129 Phone: 615-867-6000 | |
Vishant Shah, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3400 Lebanon Rd, Murfreesboro, TN 37129 Phone: 615-225-2493 | |
Dr. Valarie Readus Moore, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 3400 Lebanon Road, Murfreesboro, TN 37129 Phone: 615-867-6000 | |
Richard Earl Parrish, MD, FCCP Nephrology Medicare: Medicare Enrolled Practice Location: 1800 Medical Center Pkwy Ste 310, Murfreesboro, TN 37129 Phone: 615-849-9868 Fax: 615-898-1882 | |
Joseph Scott, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1272 Garrison Drive, Murfreesboro, TN 37129 Phone: 615-867-8010 Fax: 615-867-7945 | |
Dr. Vlada Melekhin, M.D., M.P.H. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Pkwy Ste 400, Murfreesboro, TN 37129 Phone: 615-396-6800 | |
Dr. Donald Parker Patterson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1800 Medical Center Parkway, Depaul Bldg. Ste. 400, Murfreesboro, TN 37129 Phone: 615-396-6800 Fax: 615-396-6801 |